)
Visual21 Nov 2025
Data center suppliers
Prophase Labs (PRPH) investor relations material
Prophase Labs Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary19 Nov, 2025
Executive summary
Strategic focus on unlocking value from subsidiaries such as Crown Medical Collections, BE-Smart Esophageal Cancer Test, and Nebula Genomics DNA Complete, with M&A discussions and asset sales to realize significant value multiples.
Ceased COVID-19 diagnostic testing in May 2025 due to insurer non-payment; three lab subsidiaries filed for Chapter 11 in September 2025 to pursue unpaid claims.
Emphasis on shareholder proxy voting and NASDAQ compliance as critical for advancing strategic initiatives.
Management is pursuing potential deals, including a crypto treasury strategy and other M&A opportunities, to enhance shareholder value.
Sold Pharmaloz Manufacturing and Real Estate subsidiaries in January 2025, recognizing an $8.7 million gain.
Financial highlights
Net revenue for Q3 2025 was $0.9M, down from $1.4M in Q3 2024; all revenue from consumer products as diagnostic services ceased.
Net loss from continuing operations for Q3 2025 was $6.8M ($0.16/share), compared to $5.0M ($0.26/share) in Q3 2024.
Market capitalization is approximately $12 million, with 46.1 million shares outstanding at $0.25–$0.30 per share.
Cash and equivalents at September 30, 2025 were $405K, down from $678K at year-end 2024.
Working capital deficit was $47.5M at September 30, 2025, compared to $1.5M at year-end 2024.
Outlook and guidance
Management expects significant cash inflows from Crown Medical Collections within months, potentially transforming the financial position.
12-month commercialization roadmap for BE-Smart Esophageal Cancer Test includes clinical integration, KOL engagement, EHR automation, and reimbursement strategy.
Plans to pay off debt first, then consider share buybacks and further investment in core businesses.
Management expects sufficient liquidity for at least 12 months but notes uncertainties in business growth and receivables collection.
Expects additional clinical and commercial updates for BE-Smart throughout 2026.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Prophase Labs earnings date
Q4 202527 Mar, 2026
Next Prophase Labs earnings date
Q4 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
ProPhase Labs, Inc. is a diversified company engaged in diagnostic testing, genomics, and consumer health products. Its diagnostic services division operates CLIA-certified labs, offering testing solutions for various health conditions, including infectious diseases. The company also focuses on genomics through its subsidiary, which provides genetic testing and research services aimed at improving personalized healthcare. Additionally, ProPhase Labs develops, markets, and distributes a range of over-the-counter consumer health products, primarily focused on immune support and respiratory health. The company is headquartered in Garden City, New York, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage